The TB Europe Coalition calls on the European Commission to increase public health funding to fight resurgence of tuberculosis in Europe and eradicate deadly strains.

Over 1000 patients are estimated to fall sick with tuberculosis every day across Europe – or over 380 000 yearly – signalling that there is no room for complacency when it comes to TB prevention and control.

People living with MDR-TB and their healthcare providers call for urgent action.

In TB fight, children must be a priority – World TB Day March 24

Urgent need for US$ 1.6 billion a year in international financing to prevent spread of disease.

Re: Urgent recommendations to address and resolve ongoing shortages of tuberculosis drugs in the United States

The Stop TB Partnership’s Global Drug Facility has reduced the price of several second-line drugs it supplies for the treatment of multidrug resistant tuberculosis (MDR-TB) by up to 26% compared to 2011 prices, resulting in a decrease in the overall cost of treatment.

Determining a fair and affordable price of bedaquiline is essential for timely approval and appropriate domestic and global access to the best possible therapeutic options for people with DR-TB.

Findings provide guidance for global policy and clinical approach in treatable disease that kills millions worldwide.

The guide highlights important safety and efficacy data reported thus far and offers advocacy recommendations for activists to take forward.